Literature DB >> 17294210

Treatment strategy for synchronous metastases of colorectal cancer: is hepatic resection after an observation interval appropriate?

Yasuhiro Shimizu1, Kenzo Yasui, Tsuyoshi Sano, Takashi Hirai, Yukihide Kanemitsu, Koji Komori, Tomoyuki Kato.   

Abstract

BACKGROUND: In cases of synchronous colorectal hepatic metastases, the primary colorectal cancer strongly influences on the metastases. Our treatment policy has been to conduct hepatic resection for the metastases at an interval of 3 months after colorectal resection. We examined the appropriateness of interval hepatic resection for synchronous hepatic metastasis.
MATERIALS AND METHODS: The subjects were 164 patients who underwent resection of hepatic metastasis of colorectal cancer (synchronous, 70 patients; metachronous, 94 patients). Background factors for hepatic metastasis and postoperative results were compared for synchronous and metachronous cases.
RESULTS: The cumulative survival rate for 164 patients at 3, 5, and 10 years postoperatively was 71.9%, 51.8%, and 36.6%, and the post-resection recurrence rate in remnant livers was 26.8%. Interval resection for synchronous hepatic metastases was conducted in 49 cases after a mean interval of 131 days. No difference was seen in postoperative outcome between synchronous and metachronous cases.
CONCLUSION: The outcome was similarly favorable in cases of synchronous hepatic metastasis and in cases of metachronous metastasis. Delaying resection allows accurate understanding of the number and location of hepatic metastases, and is beneficial in determining candidates for surgery and in selecting surgical procedure.

Entities:  

Mesh:

Year:  2007        PMID: 17294210     DOI: 10.1007/s00423-007-0153-x

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  16 in total

Review 1.  Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes.

Authors:  Kenzo Yasui; Yasuhiro Shimizu
Journal:  Int J Clin Oncol       Date:  2005-04       Impact factor: 3.402

2.  A new macroscopic classification predicts prognosis for patient with liver metastases from colorectal cancer.

Authors:  K Yasui; T Hirai; T Kato; A Torii; K Uesaka; T Morimoto; Y Kodera; Y Yamamura; T Kito; N Hamajima
Journal:  Ann Surg       Date:  1997-11       Impact factor: 12.969

3.  Hepatic resection for colorectal metastases: analysis of prognostic factors.

Authors:  S Ambiru; M Miyazaki; T Isono; H Ito; K Nakagawa; H Shimizu; K Kusashio; S Furuya; N Nakajima
Journal:  Dis Colon Rectum       Date:  1999-05       Impact factor: 4.585

4.  Combined colon and hepatic resection for synchronous colorectal liver metastases.

Authors:  S Lyass; G Zamir; I Matot; D Goitein; A Eid; O Jurim
Journal:  J Surg Oncol       Date:  2001-09       Impact factor: 3.454

5.  Interval hepatic resection of colorectal metastases improves patient selection.

Authors:  L A Lambert; T A Colacchio; R J Barth
Journal:  Arch Surg       Date:  2000-04

6.  Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases.

Authors:  Heidi K Chua; Karl Sondenaa; Gregory G Tsiotos; Dirk R Larson; Bruce G Wolff; David M Nagorney
Journal:  Dis Colon Rectum       Date:  2004-08       Impact factor: 4.585

7.  Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Kenichi Matsuo; Yasuhiko Nagano; Itaru Endo; Hitoshi Sekido; Shinji Togo
Journal:  Surgery       Date:  2004-09       Impact factor: 3.982

8.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis.

Authors:  Robert Martin; Philip Paty; Yuman Fong; Andrew Grace; Alfred Cohen; Ronald DeMatteo; William Jarnagin; Leslie Blumgart
Journal:  J Am Coll Surg       Date:  2003-08       Impact factor: 6.113

9.  Hepatic resection for colorectal liver metastases.

Authors:  N Hananel; J Garzon; P H Gordon
Journal:  Am Surg       Date:  1995-05       Impact factor: 0.688

10.  Surgery for synchronous hepatic metastases of colorectal cancer.

Authors:  H Bismuth; D Castaing; O Traynor
Journal:  Scand J Gastroenterol Suppl       Date:  1988
View more
  6 in total

1.  Reevaluating the Evidence for Intensive Postoperative Extracolonic Surveillance for Nonmetastatic Colorectal Cancer.

Authors:  Jonah Popp; David S Weinberg; Eva Enns; John A Nyman; J Robert Beck; Karen M Kuntz
Journal:  Value Health       Date:  2021-10-13       Impact factor: 5.101

2.  Validity of observation interval for synchronous hepatic metastases of colorectal cancer: changes in hepatic and extrahepatic metastatic foci.

Authors:  Yasuhiro Shimizu; Kenzo Yasui; Tsuyoshi Sano; Takashi Hirai; Yukihide Kanemitsu; Koji Komori; Tomoyuki Kato
Journal:  Langenbecks Arch Surg       Date:  2008-01-04       Impact factor: 3.445

3.  Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report.

Authors:  Tomoya Yokota; Tsuyoshi Sano; Yasuhiro Shimizu; Daisuke Takahari; Yoshiki Senda; Masahiro Shimura; Takashi Ura; Kohei Shitara; Yuji Nimura; Yasushi Yatabe; Kei Muro
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

4.  Ten-year survival after liver resection for colorectal metastases: systematic review and meta-analysis.

Authors:  Saleh Abbas; Vincent Lam; Michael Hollands
Journal:  ISRN Oncol       Date:  2011-06-22

5.  Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition.

Authors:  Jennie Engstrand; Cecilia Strömberg; Henrik Nilsson; Jacob Freedman; Eduard Jonas
Journal:  World J Surg Oncol       Date:  2019-12-26       Impact factor: 2.754

Review 6.  Radioembolization treatment for liver metastases.

Authors:  Joanna Kiszkaą; Bożenna Karczmarek-Borowska
Journal:  Contemp Oncol (Pozn)       Date:  2017-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.